Tim Carmichael
@TimCarmichael3
Living the dream. No free lunch on Wall Street.
$AXSM good update. Risk/reward looks quite attractive on the recent pullback. With accelerating product revenue Q/Q and expanding CNS lineup it’s easy to see why Big BioPharmas are keeping a close eye on this one💥
Despite competitive anxiety concerning alternative risk investment ops(AI, crypto, biotech, energy, etc.), Oppenheimer’s new post R&D day report($AXSM PT $183) does a good job of summarizing the ever growing multi drug CNS investment thesis for $AXSM $XBI $IBB
$VKTX VK2735 oral data release right around the corner. Big BioPharmas continue to have problems attacking the $150+ Billion Obesity market. Where are you $RHHBY $MRK $PFE $ABBV ???
Roche has axed one of the obesity assets from its $2.7B Carmot buyout, sending the molecule to the scrap heap months after hyping its potential to drive weight loss past the GLP-1 plateau. fiercebiotech.com/biotech/roche-…
$VKTX++ the outlook remains very positive for this small-cap Obesity play. Risk/reward for both traders and investors looks very promising —with oral data release imminent 💥💥💥
$VKTX *Update Currently sitting at $35 share and ~$3.9B MC. - Cash balance ~$808M • VK2735 inj obesity/diabetes candidate in two Ph3 trials • VK2809 in NASH Ph3 initiation TBD • Potential best in class Oral Dual GLP1/GIP agonist candidate currently in 13 week Ph2 trial…
Lawsuit points to alleged misconduct at Amgen-bought biotech fiercepharma.com/pharma/doctore…
Texas AG Ken Paxton increasingly relies on private lawyers | The Texas Tribune texastribune.org/2025/07/24/ken…
The Stock Market’s Gain Is Puzzling. Thank the ‘Short Squeeze. barrons.com/articles/the-s…
Axsome Therapeutics: Unlocking CNS Potential with a Multi-Product Pipeline (NASDAQ:AXSM) — NICE SUMMARY 💥💥 beyondspx.com/article/axsome…
The Cure covering The Beatles - “Hello Goodbye” (featuring James McCartney):
This Weight-Loss Stock Sank After Earnings. It’s Still a Risk for Eli Lilly, Novo Nordisk. - Barron’s stocks.apple.com/AMirFI1q2QcW_7…
AstraZeneca's blockbuster contender hits phase 3 gMG goals fiercebiotech.com/biotech/astraz…
AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trial | BioPharma Dive biopharmadive.com/news/astrazene…
🚨🚨🚨 Watch Jeffrey Epstein plead his Fifth, Sixth, and 14th Amendment rights when asked if he and Donald Trump socialized with females under the age of 18 during a 2010 deposition: Q: Have you ever had a personal relationship with Donald Trump? A. What do you mean by "personal…
Trump Administration Live Updates: Attorney General Alerted Trump His Name Appeared in Epstein Files nytimes.com/live/2025/07/2… via @NYTimes
3M's Resurgence: Innovation and Operational Rigor Drive Growth (NYSE:MMM) beyondspx.com/article/3m-s-r…
President George W. Bush and Ozzy Osbourne at the 2002 White House Correspondents Dinner
My friend OZZY has left us! What a run🔥🔥 here we are Hawaii summer ‘15 💥💥
Is it getting to pardon time to keep her mouth shut? Sounds about right. Quid pro qou.
Deputy Attorney General Todd Blanche will meet with convicted sex trafficker and Jeffrey Epstein associate Ghislaine Maxwell in the next several days, Attorney General Pam Bondi said on Tuesday morning. nbcnews.com/politics/justi…
Weight loss drugs could help treat PCOS cnbc.com/2025/07/20/wei…
For Sale: Trump is leveraging power of his office to reap profits for family businesses finance.yahoo.com/news/sale-trum…
